TITLE:
Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome

CONDITION:
Myelodysplastic Syndromes

INTERVENTION:
TLK199 HCl Liposomes for Injection

SUMMARY:

      The purpose of this study is to determine the safety and efficacy of TLK199 in patients with
      myelodysplastic syndrome (MDS).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Histologically or cytologically confirmed diagnosis of MDS

          -  Adequate liver and kidney function

          -  Ineligible for, or refusing, allogeneic bone marrow transplant

          -  At least 18 years of age

          -  Discontinuation of growth factors (e.g., G- CSF) at least 2 weeks prior to study
             entry

        Exclusion Criteria:

          -  Failure to recover from any prior surgery, or any major surgery within 4 weeks of
             study entry

          -  Pregnant or lactating women

          -  History of allergy to eggs

          -  Other investigational drugs within 14 days of study entry

          -  Chemotherapy, radiotherapy or immunotherapy within 14 days of study entry

          -  Concomitant steroids or hormones for the treatment of neoplasms
      
